EICHORCondition: Crohn's Disease · Sponsor: Lakefront Biotherapeutics NV
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
The primary objective of this study is to observe the long-term safety of filgotinib in adults who have completed or met protocol specified efficacy discontinuation criteria in a prior filgotinib treatment study in Crohn's disease (CD).
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Digestive Health Specialists Of The Southeast | Dothan, Alabama, United States | — |
| Arizona Digestive Health - Sun City | Sun City, Arizona, United States | — |
| Southern California Research Center, Inc. | Coronado, California, United States | — |
| Cedars Sinai Medical Center | Los Angeles, California, United States | — |
| Inland Empire Clinical Trials, LLC | Rialto, California, United States | — |
| UC San Diego Health Systems | San Diego, California, United States | — |
| Kaiser Permanente | San Francisco, California, United States | — |
| Clearview Medical Research, LLC | Santa Clarita, California, United States | — |
| University of Colorado Denver and Hospital | Aurora, Colorado, United States | — |
| South Denver Gastroenterology, PC | Lone Tree, Colorado, United States | — |
| Connecticut GI, PC - Research Division | Farmington, Connecticut, United States | — |
| Medstar Georgetown University Hospital | Washington D.C., District of Columbia, United States | — |
+ 474 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02914600